{
  "ticker": "AUTL",
  "company_name": "Autolus Therapeutics plc",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT03590574",
      "title": "Phase I/II Study Evaluating AUTO4 in Patients With TRBC1 Positive T Cell Lymphoma",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "T Cell Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma, Anaplastic Large Cell Lymphoma",
      "start_date": "2018-08-30",
      "completion_date": "2024-12-12",
      "enrollment": 0,
      "sponsor": "Autolus Limited"
    },
    {
      "nct_id": "NCT06799221",
      "title": "Expanded Access Program for OOS Obe-cel",
      "status": "AVAILABLE",
      "phase": "",
      "condition": "Lymphoblastic Leukemia, Acute, Adult, B Cell ALL",
      "start_date": "",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Autolus Limited"
    },
    {
      "nct_id": "NCT03289455",
      "title": "CD19 /22 CAR T Cells (AUTO3) for the Treatment of B Cell Acute Lymphoblastic Leukemia (ALL)",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "B Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Refractory Childhood Acute Lymphoblastic Leukemia, B-cell Acute Lymphoblastic Leukemia",
      "start_date": "2017-06-26",
      "completion_date": "2020-05-18",
      "enrollment": 0,
      "sponsor": "Autolus Limited"
    },
    {
      "nct_id": "NCT03287817",
      "title": "Cluster of Differentiation Antigen 19/22(CD19/22) CAR T Cells (AUTO3) for the Treatment of Diffuse Large B Cell Lymphoma",
      "status": "TERMINATED",
      "phase": "PHASE1, PHASE2",
      "condition": "Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)",
      "start_date": "2017-09-05",
      "completion_date": "2023-10-19",
      "enrollment": 0,
      "sponsor": "Autolus Limited"
    },
    {
      "nct_id": "NCT03628612",
      "title": "Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells",
      "status": "ENROLLING_BY_INVITATION",
      "phase": "PHASE2",
      "condition": "Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy, Multiple Myeloma, DLBCL, ALL, Adult and Pediatric, T Cell Lymphoma",
      "start_date": "2018-08-02",
      "completion_date": "2043-12",
      "enrollment": 0,
      "sponsor": "Autolus Limited"
    },
    {
      "nct_id": "NCT07053800",
      "title": "Obe-cel in Severe, Refractory Systemic Lupus Erythematosus With Active Lupus Nephritis",
      "status": "NOT_YET_RECRUITING",
      "phase": "PHASE2",
      "condition": "Lupus Nephritis",
      "start_date": "2025-09",
      "completion_date": "2030-02",
      "enrollment": 0,
      "sponsor": "Autolus Limited"
    },
    {
      "nct_id": "NCT07139743",
      "title": "Obe-cel in Refractory Progressive Forms of Multiple Sclerosis",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Progressive Multiple Sclerosis",
      "start_date": "2025-08-04",
      "completion_date": "2029-08-15",
      "enrollment": 0,
      "sponsor": "Autolus Limited"
    },
    {
      "nct_id": "NCT06333483",
      "title": "Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus Erythematosus",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Systemic Lupus Erythematosus",
      "start_date": "2024-02-02",
      "completion_date": "2026-12",
      "enrollment": 0,
      "sponsor": "Autolus Limited"
    },
    {
      "nct_id": "NCT04404660",
      "title": "A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia",
      "start_date": "2020-06-03",
      "completion_date": "2029-06-30",
      "enrollment": 0,
      "sponsor": "Autolus Limited"
    },
    {
      "nct_id": "NCT06173518",
      "title": "A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia, Relapsed or Refractory B Cell Non-Hodgkin Lymphoma",
      "start_date": "2023-11-16",
      "completion_date": "2027-11",
      "enrollment": 0,
      "sponsor": "Autolus Limited"
    }
  ],
  "summary": {
    "total_trials": 12,
    "by_phase": {
      "PHASE1, PHASE2": 5,
      "": 1,
      "PHASE2": 3,
      "PHASE1": 3
    },
    "by_status": {
      "COMPLETED": 2,
      "AVAILABLE": 1,
      "TERMINATED": 2,
      "ENROLLING_BY_INVITATION": 1,
      "NOT_YET_RECRUITING": 1,
      "RECRUITING": 4,
      "ACTIVE_NOT_RECRUITING": 1
    },
    "active_trials": 6,
    "completed_trials": 2,
    "conditions": [
      "Acute Lymphocytic Leukemia (ALL)",
      "B Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Refractory Childhood Acute Lymphoblastic Leukemia, B-cell Acute Lymphoblastic Leukemia",
      "Lupus Nephritis",
      "Lymphoblastic Leukemia, Acute, Adult, B Cell ALL",
      "Multiple Myeloma",
      "Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy, Multiple Myeloma, DLBCL, ALL, Adult and Pediatric, T Cell Lymphoma",
      "Progressive Multiple Sclerosis",
      "Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia",
      "Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia, Relapsed or Refractory B Cell Non-Hodgkin Lymphoma",
      "Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)",
      "Systemic Lupus Erythematosus",
      "T Cell Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma, Anaplastic Large Cell Lymphoma"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:16:47.687531",
    "search_query": "Autolus Therapeutics plc",
    "url": "https://clinicaltrials.gov/search?term=Autolus+Therapeutics+plc"
  }
}